{"id":4440,"date":"2023-06-13T17:36:02","date_gmt":"2023-06-13T21:36:02","guid":{"rendered":"https:\/\/www.med.unc.edu\/toxicology\/?post_type=directory&#038;p=4440"},"modified":"2023-09-06T15:10:20","modified_gmt":"2023-09-06T19:10:20","slug":"shehzad-z-sheikh-md-phd","status":"publish","type":"directory","link":"https:\/\/www.med.unc.edu\/toxicology\/directory\/shehzad-z-sheikh-md-phd\/","title":{"rendered":"Shehzad Z. Sheikh, MD, PhD"},"content":{"rendered":"<p><strong>Institution:<\/strong><\/p>\n<p><a href=\"https:\/\/www.med.unc.edu\/\">UNC School of Medicine<\/a><\/p>\n<p><strong>About:<\/strong><\/p>\n<p>The human Inflammatory Bowel Diseases (IBDs), Crohn\u2019s disease (CD) and ulcerative colitis (UC) affect 3 million Americans. The overall incidence of the IBDs is increasing for unknown reasons. There is no cure for IBD: Consequently, the chronic nature of IBD is therefore a steadily increasing burden on the healthcare system. Current medical and surgical approaches are insufficient for many IBD patients who endure attempts at trying different combinations of therapies over their entire life. As a physician-scientist I am dedicated to the care of people with IBD while actively pursuing research that contributes to our understanding of Crohn\u2019s disease (CD) and ulcerative colitis (UC), with the ultimate goal of finding a cure. To accomplish these goals we have developed projects that bridge our work in animal models of IBD to human IBD with advanced technologies in epithelial cell biology, immunology, microbiology, molecular biology and high throughput genomics.<\/p>\n<p><a href=\"https:\/\/sheikhlab.web.unc.edu\/\"><strong>Website<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=shehzad+sheikh\"><strong>Publications<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Institution: UNC School of Medicine About: The human Inflammatory Bowel Diseases (IBDs), Crohn\u2019s disease (CD) and ulcerative colitis (UC) affect 3 million Americans. The overall incidence of the IBDs is increasing for unknown reasons. There is no cure for IBD: Consequently, the chronic nature of IBD is therefore a steadily increasing burden on the healthcare &hellip; <a href=\"https:\/\/www.med.unc.edu\/toxicology\/directory\/shehzad-z-sheikh-md-phd\/\" aria-label=\"Read more about Shehzad Z. Sheikh, MD, PhD\">Read more<\/a><\/p>\n","protected":false},"featured_media":4446,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"class_list":["post-4440","directory","type-directory","status-publish","has-post-thumbnail","hentry","odd"],"acf":[],"_upd_display_name":["Shehzad Sheikh"],"_upd_reverse_display_name":["Sheikh, Shehzad"],"_upd_last_name":["Sheikh"],"_upd_first_name":["Shehzad"],"_upd_sortorder_override":[],"_upd_sortorder":["1"],"_upd_gallery_summary":["<strong>Office:<\/strong> 7312B MBRB<strong> | Phone:<\/strong> (984) 974-7131 <strong>| <a href=\"mailto:sheisx@med.unc.edu\">Email <\/a><\/strong>\r\n\r\nPrime Focus: Inflammatory Bowel Diseases (Crohn's disease and ulcerative colitis) Autoimmune enteropathies Celiac disease."],"_upd_no_link":[],"_upd_degree1":[],"_upd_degree2":[],"_upd_email":[],"_upd_phone":[],"_upd_address":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/directory\/4440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/directory"}],"about":[{"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/types\/directory"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/directory\/4440\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/media\/4446"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/toxicology\/wp-json\/wp\/v2\/media?parent=4440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}